Schedule 13D ownership disclosure

IDENIX PHARMACEUTICALS INC

Security class unavailable · CUSIP: 45166R204

Event date: 2014-06-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
22,477,560
Percent of class
14.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000310158-14-000046
Form type
SC 13D
Filer
IDENIX PHARMACEUTICALS INC
CIK
CIK 1093649
Filed
Jun 13, 2014
Reporting period
Jun 08, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub